Benefits Think Essential questions benefit leaders must ask about GLP-1 coverage

Published Updated 5 Min Read

Hand holding pill between two fingers
Adobe Stock

Obesity continues to be one of the most misunderstood and undertreated diseases in the United States. This, despite being the leading cause of serious comorbidities like type 2 diabetes, hypertension, some cancers, and obstructive sleep apnea — all drivers of significant healthcare spending

We continue to see advances in medical research and obesity treatments, yet, far too often, coverage decisions are swayed by long-standing misconceptions about obesity. Many of us were raised in a culture that blamed people for their weight struggles. We all saw commercials for fad diets, magazines fat-shaming celebrities, endless point counting and silly diet products like fat-free cookies. Diet culture has undeniably influenced all of us.

Jen Cressman
Chief commercial officer

Jen Cressman is the chief commercial officer at Form Health, the national leader in science-based obesity care. Jen is a veteran of the healthcare industry, building and leading exceptional … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form